SCHEMBL5841487

SCHEMBL5841487

O=C(NCCc1ccccn1)C1CCNC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
HSD11B1 P28845 1/20 0.50
ALOX5AP P20292 1/20 0.48
KDM4E B2RXH2 2/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
FPR3 P25089 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
CNR1 P21554 1/20 0.45
KCNH2 Q12809 1/20 0.45
MCHR1 Q99705 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29542064 0.93 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL21640657 0.90 HSD11B1 (0.54) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
Hydrochloric Acid SCHEMBL30585928 0.90 HSD11B1 (0.54) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL17130350 0.87 KMT2A (0.55) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL17055772 0.87 KMT2A (0.55) ALDH1A1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL29542525 0.80 TSHR (0.56) SMN1; SMN2CYP3A4KDM4EMEN1KMT2A
SCHEMBL4387100 0.79 KMT2A (0.60) ALDH1A1SMN1; SMN2CYP3A4KDM4EMEN1
SCHEMBL18951306 0.76 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL20861762 0.76 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL16686677 0.75 RAB9A (0.53) ALDH1A1RAB9ANPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7067549-B2 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2006-06-27 US disclosed
US-20050192292-A1 Pyrrolidone carboxamides ACTELION PHARMACEUTICALS AG (CH) 2005-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050192292-A1 Pyrrolidone carboxamides NPY1R, NPY5R, NPY2R ALDH1A1 3034/4885SMN1; SMN2 3678/4885CYP1A2 2074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.